Sundaram Multi Pap Board of Directors
Get the latest insights into the leadership at Sundaram Multi Pap. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Amrut P Shah | Chairman & Managing Director |
| Mr. Shantilal P Shah | Whole Time Director |
| Mr. Krunal S Shah | Whole Time Director |
| Mr. Kalpesh B Parekh | Independent Director |
| Mr. Mahesh Devji Bhanushali | Independent Director |
| Ms. Jyoti C Gala | Independent Woman Director |
Sundaram Multi Pap Share price
SUNDARAM
1.99
0.01 (0.51%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:56 IST
BUYSELL
Today's High
2.08
Today's Low
1.96
52 Week Low
1.78
52 Week High
3.10
The current prices are delayed, login to your account for live prices
LoginSundaram Multi Pap FAQs
The board at Sundaram Multi Pap consists of experienced professionals, including Mr. Amrut P Shah , Mr. Shantilal P Shah , and others, overseeing the company’s strategic and corporate governance.
Directors at Sundaram Multi Pap are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Amrut P Shah is the current chairman at Sundaram Multi Pap.
Executive directors at Sundaram Multi Pap are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sundaram Multi Pap adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sundaram Multi Pap, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.